| # | Drug | Count |
|---|---|---|
| 0 | CYTARABINE | 124 |
| 1 | ETOPOSIDE | 78 |
| 2 | CYCLOPHOSPHAMIDE | 77 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 77 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 77 |
| 5 | METHOTREXATE SODIUM | 76 |
| 6 | METHOTREXATE | 75 |
| 7 | VINCRISTINE SULFATE | 47 |
| 8 | DEXAMETHASONE | 41 |
| 9 | DEXAMETHASONE 1.5 MG | 41 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCERIN 20% | 1 | 0.0588 |
| 1 | DAUNORUBICIN HYDROCHLORIDE | 11 | 0.0067 |
| 2 | GRANULOCYTE COLONY STIMULATING FACTOR | 6 | 0.0028 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 22 | 0.0026 |
| 4 | SODIUM CITRATE | 3 | 0.0024 |
| 5 | BISACODYL 5MG | 2 | 0.0023 |
| 6 | GEMTUZUMAB OZOGAMICIN | 8 | 0.0022 |
| 7 | DEXRAZOXANE FOR INJECTION | 2 | 0.0021 |
| 8 | NELARABINE | 2 | 0.0021 |
| 9 | TOPOTECAN HYDROCHLORIDE | 5 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 159 |
| 1 | Alkylating Drug [EPC] | 94 |
| 2 | Corticosteroid [EPC] | 93 |
| 3 | Topoisomerase Inhibitor [EPC] | 81 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 75 |
| 5 | Platinum-based Drug [EPC] | 65 |
| 6 | Azole Antifungal [EPC] | 38 |
| 7 | Leukocyte Growth Factor [EPC] | 33 |
| 8 | Benzodiazepine [EPC] | 31 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 8 | 0.0022 |
| 1 | Actinomycin [EPC] | 4 | 0.0018 |
| 2 | Asparagine-specific Enzyme [EPC] | 17 | 0.0013 |
| 3 | Topoisomerase Inhibitor [EPC] | 81 | 0.0011 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 6 | 0.0007 |
| 5 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 159 | 0.0006 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 8 | Alkylating Drug [EPC] | 94 | 0.0004 |
| 9 | Glycopeptide Antibacterial [EPC] | 22 | 0.0003 |